Robert L. Bard

Prostate Cancer Decoded: Non-Invasive Breakthrough Treatments

Buch

The Facts of Prostate Cancer 2/3 of men over age 50 have low grade tumors or potential cancer cells in their prostate. Only 10% will develop clinically aggressive prostate cancer. These non-invasive exams tell if a tumor is aggressive or not with an accuracy exceeding traditional biopsy results and correlate well with prognosis according to the latest international cancer conferences. The PSA test has a poor correlation with cancer detection. The digital rectal exam is more accurate in detecting high grade tumors than the PSA level. Biopsies are random, invasive and may spread tumor cells. New non-invasive treatments are guided by advanced ra… Mehr

CHF 23.90

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V106: Fremdlagertitel. Lieferzeit unbestimmt

Produktdetails

ISBN: 978-1-60037-346-6
EAN: 9781600373466
Produktnummer: 3435650
Verlag: Morgan James Pub
Sprache: Englisch
Erscheinungsjahr: 2007
Seitenangabe: 168 S.
Masse: H25.5 cm x B17.7 cm x D1.1 cm 494 g
Gewicht: 494

Über den Autor

Dr. R. Bard is a radiologist specializing in prostate MRI and prostate sonography. He uses an automated ultrasound doppler 3-D unit designed specifically for examining the prostate at ultrahigh resolution to detect early cancer and follow treatment status. The sonogram study is combined with a special computerized MRI to determine metastatic spread and confirm results of clinical therapies.